European Pharmaceutical Review Issue 6 2019
Posted: 18 December 2019 | European Pharmaceutical Review | No comments yet
In this issue are articles that explore the impact of M&As within the life science industry, discuss the security trends for medicinal packaging and investigate genotoxic impurities within pharmaceutical products. Also included are features on nanobot drug delivery systems and Raman as an effective analytical approach.
Included in this issue:
- REGULATORY INSIGHT
The real reason you’re struggling to stay compliant
Rebecca Godfrey, Etheo - FORMULATION, DEVELOPMENT & DELIVERY
Formulation confidence with recombinant albumin: the benefits of a versatile stabiliser for challenging formulations
Dr Phil Morton, Albumedix - BIOPROCESSING & BIOPRODUCTION
Viral vectors for gene therapy
Dr Philip Probert and Dr Stuart Jamieson, CPI Biologics - BREXIT
Medical devices: recent developments and the potential impact of Brexit
Paul Ranson, Morgan Lewis - MANUFACTURING, PACKAGING & LOGISTICS
EU MDR: best practices for bringing enterprise labelling under control
Graham Francis, Kallik - QA/QC & ANALYTICAL TECHNIQUES
Learning from clinical microbiologists – culturomics and metagenomics
Jeanne Moldenhauer, Excellent Pharma Consulting
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
